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Metastatic bladder cancerHigh steady-state reactive oxygen species (ROS) production has been implicated with metastatic disease pro-
gression. We provide new evidence that this increased intracellular ROS milieu uniquely predisposes metastatic
tumor cells to hypoxia-mediated regulation of thematrixmetalloproteinaseMMP-1. Using a cell culturemetasta-
tic progression model we previously reported that steady-state intracellular H2O2 levels are elevated in highly
metastatic 253J-BV bladder cancer cells compared to their non-metastatic 253J parental cells. 253J-BV cells dis-
play higher basal MMP-1 expression, which is further enhanced under hypoxic conditions (1% O2). This
hypoxia-mediated MMP-1 increase was not observed in the non-metastatic 253J cells. Hypoxia-induced MMP-
1 increases are accompanied by the stabilization of hypoxia-inducible transcription factors (HIFs)-1α and HIF-
2α, and a rise in intracellular ROS in metastatic 253J-BV cells. RNA interference studies show that hypoxia-
mediated MMP-1 expression is primarily dependent on the presence of HIF-2α. Further, hypoxia promotes mi-
gration and spheroid outgrowth of only themetastatic 253J-BV cells and not the parental 253J cells. The observed
HIF stabilization, MMP-1 expression and migration under hypoxia are dependent on increases in intracellular
ROS, as these effects are attenuated by treatment with the antioxidant N-acetyl-L-cysteine. These data show
that ROS play an important role in hypoxia-mediated MMP-1 expression and that an elevated intracellular
redox environment, as observed in metastasis, predisposes tumor cells to an enhanced hypoxic response. It fur-
ther supports the notion that metastatic tumor cells are uniquely able to utilize intracellular increases in ROS to
drive pro-metastatic signaling events and highlights the important interplay between ROS and hypoxia in
malignancy.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Reactive oxygen species (ROS), including superoxide anion (O2•−)
and hydrogen peroxide (H2O2), are produced by various enzymatic
and chemical processes within the cell. Tumor cells have been shown
to display higher steady state ROS levels, which appear to further in-
crease during metastatic progression [1–5]. While NADPH oxidase
enzymes are implicated in regulating ROS production in response
to growth factors and cytokines, mitochondria serve as a major site of
O2•− production as a result of electron leakage during the normal course
of cellular respiration, and the one electron reduction of molecular oxy-
gen (O2). O2•− is in turn spontaneously or enzymatically dismuted by
manganese superoxide dismutase (Sod2) to the potent signaling oxi-
dant H2O2. Increases in tumor cell ROS have been implicated with
redox-dependent signaling pathways by regulating the activity of phos-
phatases, kinases and transcription factors [3,4,6–8]. We and othersI grant R00CA143229.
cology, Penn State College of
850, Hershey, PA 17033, USA.have shown that steady-state increases in intracellular H2O2 control
metastatic behavior, including invasion and migration [1,2,9,10]. These
shifts in H2O2 also drive the expression of pro-metastatic proteins
such as Vascular Endothelial Growth Factor (VEGF) andMatrixMetallo-
proteinase (MMP) family members [1,11]. MMPs play an essential role
in extracellular matrix (ECM) remodeling during morphogenesis, em-
bryogenesis and wound healing, and their increased expression in can-
cer is associatedwith tumor angiogenesis, invasion andmetastasis [12–
15]. Inmany cancers aberrantMMP-1 expression is observed in invasive
disease and is associated with poor patient outcome [16–19]. MMP-1 is
an interstitial collagenase andmember of the zinc-dependent endopep-
tidase family. It provides metastatic tumor cells the ability to clear the
ECM and extravasate from the primary tumor tissue into the blood
and lymph to colonize distant metastatic sites. MMP-1 activity is tightly
controlled by proteolytic cleavage, including the negative regulation by
tissue inhibitors of metalloproteinases (TIMPs), expression of which is
often decreased in cancer. While transcription of MMP-1 is generally
low in normal epithelia, it is enhanced in response to numerous stimuli,
including growth factors, cytokines and hormones [20,21]. In addition,
exogenous sources of ROS, such as cigarette smoke and UV irradiation,
have been shown to induce MMP-1 expression [22,23]. We have
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ronment of tumor cells can drive MMP-1 transcription via redox-
mediated JNK and ERK1/2 signaling pathways and redox responsive el-
ements on the MMP-1 promoter [24–26].
Solid tumors commonly grow beyond the limits of oxygen diffusion
and engage a hypoxic response to promote angiogenesis, invasion, epi-
thelial to mesenchymal transition (EMT), cancer stem-cell self-renewal
and cell survival [27]. The cellular response to hypoxia requires the in-
duction of hypoxia inducible transcription factors (HIFs), comprising
the oxygen labileα-subunits (HIF-1α, HIF-2α, and HIF-3α) and a stable
β-subunit. In normoxia, HIF-α is hydroxylated by prolyl hydroxylase
(PHD) in the presence of O2, Fe(II), 2-oxoglutarate and ascorbate. Hy-
droxylated HIF-α is then ubiquitylated via interaction with the von
Hippel-Lindau (pVHL), resulting in subsequent degradation by the pro-
teasome [28–30]. When O2 is limiting, HIF-α is not hydroxylated, and
stabilizes to heterodimerize with HIF-1β. This complex binds hypoxic
response elements (HRE) of promoters, activating transcription of
genes involved in the regulation of erythropoiesis, glycolysis, angiogen-
esis, cell cycle, and survival. High HIF-1α andHIF-2α expression is asso-
ciated with the poor prognosis of a number of cancer types [31]. Recent
evidence suggests that HIF-1α has a dominant role in controlling
responses to acute hypoxia, whereas HIF-2α drives the response to
chronic low oxygen exposure and may be an important driver in
tumorigenisis and metastatic progression [32,33].
Hypoxia also increases mitochondrial ROS production, which con-
tributes to the stabilization of HIFs [34,35]. Complex III within the mito-
chondrial electron transport chain has been shown to be the major
source of O2•− production in response to hypoxia [36–38]. A number of
mechanisms have been proposed that result in consequential HIF stabi-
lization in response to ROS (and reactive nitrogen species), including
the oxidation of Fe(II)-bound PHD, the involvement of ROS-mediated
fenton chemistry to shift the Fe(II) pool to Fe(III) thereby limiting PHD
activity, S-nitrosylation, and redox-regulation of signaling pathways
that either lead to PHD inactivation and transcriptional repression or
HIF stabilization and transcriptional/translational activation [39–44].
These reports all suggest that there is a strong interplay between ROS
and hypoxia, yet it remains unknown if these two mechanisms con-
verge to regulate expression of MMP-1 during metastatic progression.
While ROS and hypoxia have separately been shown to enhance
MMP-1 expression, it has not been established that hypoxia mediated
MMP-1 expression is dependent on ROS.
We previously demonstrated that a progression tometastasis results
in elevated levels of intracellular ROS in bladder cancer cells, and that
metastatic cells are able to survive and utilize the endogenous increases
in H2O2 to drive redox-dependent, pro-metastatic signaling [1,9]. Given
that metastatic tumor cells are often exposed to environmental condi-
tions of low oxygen, we set out to investigate how increased steady-
state ROS levels inﬂuence the response of metastatic tumor cells to hyp-
oxia. Using a cell culture model of metastatic progression we found that
an elevated steady-state redox milieu uniquely predisposes metastatic
cancer cells to hypoxia-mediated MMP-1 regulation in a ROS-
dependent manner.
2. Material and methods
2.1. Cell culture, treatment and transfection
Non-metastatic 253J and the related metastatic variant cell line
253J-BV were maintained as described previously [1,9,45]. Cells were
pretreated in Dulbecco's modiﬁed Eagle's medium (DMEM) with 10%
FBS and 2 mmol/l N-acetyl-L-cysteine (NAC; Sigma-Aldrich) for 18 h,
followed by the same treatments in serum-free media for the duration
of the experiments. Cells were treated with H2O2 (Sigma-Aldrich) in
serum-free DMEM. For studies involving hypoxic conditions (1% O2),
cells were incubated in a hypoxia chamber (ProOx C21, Biospherix)
for 18 h. GM6001 was purchased from Calbiochem and cells weretreated for 24 h with 30 μM. siRNA was transfected for 24 h using
Lipofectamine® RNAiMAX Transfection Reagent (Invitrogen Life Tech-
nologies) and Dharmacon SMARTpool siRNAs for HIF-1α (ON-
TARGETplus HIF-1α siRNA), HIF-2α (ON-TARGETplus HIF-2α siRNA),
and non-targeting scramble siRNA.
2.2. RNA extraction and cDNA
Total RNAwas extracted from bladder cancer cell lines using RNeasy
mini Kit (Qiagen). The concentration of total RNAwasmeasured using a
Nanodrop 2000 spectrophotometer (Thermo Scientiﬁc) and ﬁrst strand
cDNA synthesis of 1 μg total RNA was carried out using iScrip™ cDNA
Synthesis-Kit (Bio-Rad).
2.3. Real time PCR
Real time semi-quantitative RT-PCR was carried out on an Applied
Biosystems 7500 Real-Time PCR cycler, with the following primer
pairs: HIF-1α, 5′-TGCTCATCAGTTGCCACTTCC-3′ (forward) and 5′-
CCAAATCACCAGCATCCAGAAGT-3′ (reverse); HIF-2α 5′-AGTGCATCAT
GTGTGTCAACTACG-3′ (forward) and 5′-GGGCTTGAACAGGGATTCAG
TC-3′ (reverse); MMP-1, 5′-CCAAACCCACTCCACCTTAC-3′ (forward)
and 5′-TCATCTTTCCCTTGCGGTA-3′ (reverse); VEGF, 5′-GCTGCTCTAC
CTCCACCATGC-3′ (forward) and 5′-CCATGAACTTCACCACTTCGTG-3′
(reverse); β-actin, 5′-CTCTTCCAGCCTTCCTTCCTG-3′ (forward) and 5′-
CAGCACTGTGTTGGCGTACAG-3′ (reverse). The reaction components
were mixed with 10 μl of SYBR master enzyme mix, 5 μl of cDNA
(10 ng/μl), 0.2 μl of each primer (10 μM) and 4.6 μl of nuclease free
water. The reaction conditions were 95 °C for 10 min, 40 cycles of 95 °C
for 15 s, 59 °C for 30 s and95 °C for 15 s. Themelting curveswere analyzed
from 60 °C to 95 °C with continuous ﬂuorescence reading. Data were
analyzed using the comparative CT method with values normalized to
β-Actin levels and expressed relative to levels in untreated 253J cells.
2.4. Immunoblotting
To analyze secreted MMP-1 proteins in serum-free media, superna-
tants were harvested and concentrated 10-fold, using Amicon ultra-4
centrifugal ﬁlters. The protein amount of concentrated supernatant
was determined using BCA reagent (Thermo Scientiﬁc). The superna-
tant (25 μg protein)was loadedon SDS-PAGE (4–12%, Bio-Rad) andpro-
teins were transferred to nitrocellulose membranes. Following transfer,
membranes were incubated with primary anti-MMP-1 antibody
(Millipore) in TBS with 0.1% Tween 20 overnight at 4 °C. For HIF-1α
and HIF-2α protein analysis, cells were cultured under hypoxic condi-
tions (1% O2) for 18 h. Cells were immediately lysed in 2× SDS sample
buffer and equal amounts loaded on SDS-PAGE (4–12%, Bio-Rad),
followed by protein transfer. Membranes were incubated with primary
anti-HIF-1α or HIF-2α antibody (Cell Signaling) in 5% nonfat dry milk/
TBS with 0.1% Tween 20 overnight at 4 °C. Following secondary anti-
body incubation blots were visualized using the SuperSignal West
Femto Chemiluminescent substrate (Thermo Scientiﬁc).
2.5. Oxidation of 2′,7′-dichlorodihydroﬂuorescein diacetate (H2DCFDA)
and MitoSOX
Intracellular oxidation of H2DCFDA to 2′,7′-dichloroﬂuorescein
(DCF) was measured using ﬂow cytometry. Adherent cells were
trypsinized for 5min, followed by the addition of growthmedia to inac-
tivate trypsin. Cells pelleted by centrifugation at 1500 rpm for 5 min
were washedwith PBS, followed by resuspension in growthmedia con-
taining H2DCFDA (Life Technologies) for 30 min at 37 °C in the dark.
Cells were collected by centrifugation and washed with PBS, followed
by resuspension in 1% BSA/PBS. The samples were kept on ice in the
dark for ﬂow cytometric analysis. Cells were analyzed using an
ImageStream (Amnis) imaging ﬂow cytometer with a 488 nm laser to
2595D.H. Shin et al. / Biochimica et Biophysica Acta 1852 (2015) 2593–2602detect oxidized ﬂuorescent DCF, and ﬂuorescence intensities and im-
ages of at least 1000 single cells collected. Results represent average
ﬂuorescence intensity ± SEM. Mitochondrial O2•− was measured by
assessing the oxidation and ﬂuorescence of the MitoSOX Red dye (Life
Technologies), following the manufacturer's protocol. Cells seeded on
a glass bottom culture dish (MatTeK)were rinsedwith Hank's balanced
salt solution (HBSS) and treatedwith 5 μMMitoSOX Red dye for 30min
at 37 °C in the dark. Following gentle washing in HBSS cells stainedwith
MitoSOXRed dyewere examined using a Nikon FluorescenceMicrosco-
py. 30–52 cells/image were analyzed and ﬂuorescent intensities mea-
sured using ImageJ software, following background correction. Results
were calculated as the average intensity of three images± SEM, and ex-
periments were carried out in triplicate.
2.6. Wound healing assay
For analysis of migration, cells were trypsinized and 2 × 104 of cells
were replated into IBIDI 35 mm μ-dishes and cultured overnight to
reach conﬂuency. The next day, the inserts were removed to expose a
cell free gap (“wound”). Cells were washed with PBS and serum free
media was added. Migration was monitored by microscopy imaging at
time 0 and 18 h, and the number of cells migrated into the wound
counted.
2.7. Spheroid formation and outgrowth assays
Bladder cancer cell lines were seeded (1000 cells/well) into 96 well
round bottom ultra-low attachment (ULA) plates (Corning) and
allowed to form anchorage independent spheroid aggregate for 72 h
under normal culture conditions with fully supplemented media. 24-
well plates were coated overnight at 37 °C with 5 μg/ml type I collagen,
type IV collagen and ﬁbronectin in PBS. The spheroids were added to
each of the coatedwells under normoxia or hypoxia and themovement
of cells escaping from the spheroid into the surrounding ECM proteins
monitored over 18 h. This was quantiﬁed as percentage change in the
area covered by tumor cells using Image J software.
2.8. Statistical analysis
Data are expressed as mean ± SEM from at least 3 independent ex-
periments. Statistical analysis was performed using ANOVA formultiple
comparisons or T-tests for 2 group analysis with normal distribution,
using Prism 6 (GraphPad software).
3. Results
3.1. Hypoxia drives MMP-1 transcription in metastatic cancer cells with
high intracellular steady-state ROS
In the present study we used a bladder cancer metastatic progres-
sion model to assess the interplay between hypoxia and ROS on MMP-
1 expression and metastasis. This model was ﬁrst described by Dinney
et al., who derived a highly metastatic cell line (253J-BV) from a
human bladder adenocarcinoma parental cell line (253J-P), following
ﬁve successive orthotopic transplantations into the bladder wall of
nude mice [45]. Using a redox sensitive mitochondria-targeted GFP
probe (RoGFP) and by directly measuring intracellular H2O2 levels bio-
chemically, we previously demonstrated that the highly metastatic
bladder cancer cell line 253J-BV displays higher steady state intracellu-
lar ROS levels compared to the related non-metastatic parental variant
253J (steady state H2O2 levels: 253J: 18.09 ± 4.07 pM; 253J-BV:
31.08 ± 0.29 pM) [1]. 253J-BV cells also exhibited alterations in their
antioxidant enzyme levels, with highmanganese superoxide dismutase
(Sod2) and low catalase expression, which we believe enhances the
high steady-state H2O2 phenotype in these cells [1]. As a consequence,
253J-BV cells displayed high redox-dependent MMP-9 and VEGFexpression, and increased migration and invasion compared to the
parental 253J line [1,9]. Moreover, we demonstrated that the forced ex-
pression of Sod2 and increased steady-state ROS levels induce transcrip-
tion of MMP-1 in ﬁbrosarcoma HT-1080 cells [24,25,46]. In agreement
with these ﬁndings, 253J-BV cells with higher steady-state redox status
displayed signiﬁcantly higher MMP-1 mRNA levels than 253J cells
under normoxic (21% O2) conditions (Fig. 1A). We next assessed if the
difference in steady-state redox status inﬂuences the response of meta-
static tumor cells to hypoxia, bymonitoring the effects of low oxygen on
transcription of the pro-metastatic genesMMP-1 and VEGF. Interesting-
ly, the exposure of cells to hypoxia (1%O2) further increasedMMP-1 ex-
pression. However this effect was primarily observed in the metastatic
253J-BV cells,which display higher steady-state H2O2 levels.MMP-1 ex-
pression in response to hypoxia was also demonstrated in other aggres-
sive bladder cancer cell lines, with the highest increases observed in the
highly tumorigenic HT1197 cell line, while the less aggressive RT4 and
T24 displayed lower or no signiﬁcant changes in MMP-1 levels, respec-
tively (Supplementary Figure S1A). These data suggest that the hypoxic
regulation of MMP-1 is coincident with the acquisition of themalignant
phenotype and may be dependent on the intracellular redox threshold
of tumor cells.
3.2. Hypoxia-regulated MMP-1 transcription is ROS-dependent
Based on the previously established interplay between hypoxia and
ROS, we next investigated whether hypoxia modulates MMP-1 expres-
sion in a ROS-dependent manner. Treatment of hypoxic cells with the
antioxidant NAC signiﬁcantly decreased the mRNA level of MMP-1 in
253J-BV cells, but had no effect on MMP-1 levels in 253J cells under
both normoxic (21% O2) and hypoxic (1% O2) conditions (Fig. 2A). Sim-
ilarly, hypoxia-mediated MMP-1 expression of HT1197 was also redox-
dependent, while thiswas not observed in thenon-invasive RT4 cell line
(Supplementary Fig. S1B). Hypoxia-driven VEGF mRNA increases were
also signiﬁcantly impaired by administration of NAC (Fig. 2B). We
next assessed if the metastasis-speciﬁc hypoxia-mediated increase in
MMP-1 mRNA translates to higher MMP-1 protein expression. Indeed,
the exposure of 253J-BV cells to 1% O2 signiﬁcantly increased MMP-1
protein excretion into the media and this was attenuated following
treatment with NAC, suggesting a redox-dependent regulatory mecha-
nism (Fig. 2C andD). Again, this increase inMMP-1 proteinwas only ob-
served in 253J-BV cells. The oxidation of the redox-sensitive dye
H2DCFDA was also enhanced in 253J-BV cells under hypoxic condi-
tions (Fig. 3A and B), and ﬂuorescence of the mitochondria-
targeted redox sensor MitoSOX was similarly increased in response
to hypoxia (Fig. 3C and D). These data suggest that hypoxic ROS gen-
eration selectively drives MMP-1 transcription in metastatic tumor
cells.
3.3. Inhibition of HIF-2α attenuates hypoxia-mediated MMP-1 transcription
HIF-1α andHIF-2α-targeted siRNAswere used to determinewheth-
er the hypoxia-mediated redox-regulation of MMP-1 can be attributed
to HIF transcription factors. Of the two transcription factors, abrogation
of HIF-2α expression signiﬁcantly decreases both MMP-1 and VEGF
levels in 253J-BV cells in response to hypoxia (Fig. 4A and B). HIF-1α
knockdown only slightly decreased MMP-1 and VEGF mRNA levels,
with double knockdown of HIF-1α andHIF-2α having an additive effect
in reducing the hypoxic expression of both genes in 253J-BV cells.
Knockdown of HIF-1α and HIF-2α did not affect levels of MMP-1 in
non-metastatic 253J cells under normoxia or hypoxia (Fig. 4). These
ﬁndings suggest that HIF-2α is predominantly involved in the hypoxic
induction of MMP-1 in metastatic bladder cancer cells. Although not
statistically signiﬁcant, a consistent trend in decreased MMP-1 and
VEGF mRNA levels was observed when HIF-1α and HIF-2α were
knocked down in 253J-BV cells at 21% O2, suggesting that the enhanced
Fig. 1.Hypoxia induces transcription of MMP-1 inmetastatic 253J-BV cells, but not in the non-metastatic parental cell line 253J. A. Expression of MMP-1 is increased only in 253J-BV cells
following exposure to hypoxia (H, 1%O2 for 18 h;N=normoxia, 21%O2), as assessed by semi-quantitative real-time RT-PCR analysis. B. Expression analysis of VEGF in response to hypoxia
in 253J and 253J-BV cells Fold-increases inmRNA levels are expressed relative to normoxic culture conditions. (A& B: n=3, average± SEM; **p b 0.01, ***p b 0.001, ANOVA,with Tukey's
post-test).
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to HIF-dependent regulation ofMMP-1 and VEGF even under normoxia.
3.4. Hypoxia-mediated HIF-1α and HIF-2α protein stabilization is
ROS-dependent in metastatic 253J-BV cells
We next determined whether hypoxia-induced HIF-1α and HIF-2α
protein stabilization is ROS dependent in our model. Even under
normoxic conditions 253J-BV cells displayed increased HIF-1α protein
levels compared to 253J cells and these were decreased following treat-
mentwith NAC. This suggests that the increased steady-state redox sta-
tus enhances the stability of HIF-1α in metastatic cells (Fig. 5A and B).Fig. 2. Antioxidant treatment attenuates hypoxia-mediatedMMP-1 RNA and protein expression
BV cells exposed to hypoxia (H, 1% O2) for 18 h, which is abrogated by treatment with the antio
sion is ROS-dependent. Excreted MMP-1 protein was detected by Western blotting as describe
18 h) was abrogated following incubation with NAC. D. Quantiﬁcation of MMP-1 protein levels
****p b 0.0001, ANOVA with Tukey's post test).HIF-2α protein levels were undetectable in both cell lines cultured
under 21% O2 (Fig. 5A and C). However, in response to hypoxia both
HIF-1α and HIF-2α protein levels were markedly increased in 253J-BV
cells, with only modest changes observed in the non-metastatic variant
253J (Fig. 5A–C). Treatmentwith the antioxidant NAC showed that both
HIF-1α and HIF-2α stabilization in response to 1% O2 is at least in part
ROS-dependent in metastatic 253J-BV cells (Fig. 5A–C). Although HIF-
1α and HIF-2α mRNA levels were higher in 253J-BV cells compared
with 253J cells in 21% O2 conditions, hypoxia and antioxidant treatment
did not alter mRNA levels in either cell line (Fig. 5D and E). These data
indicate that the ROS-dependent effects of hypoxia are elicited at the
level of HIF protein stabilization.in metastatic 253J-BV cells. MMP-1 (A) and VEGF (B) mRNA levels are increased in 253J-
xidant N-acetyl-L-cysteine (NAC, 2 mmol/l). C. Hypoxia-mediatedMMP-1 protein expres-
d in methods. Increased MMP-1 expression in 253J-BV cells in response to hypoxia (% O2,
normalized to actin. (A, B & D: n = 3, average ± SEM; *p b 0.05, **p b 0.01, ***p b 0.001,
Fig. 3.DCF andMitoSOX ﬂuorescence is enhanced inmetastatic 253J-BV cells in response to hypoxia. A. Levels of DCF ﬂuorescence in 253J-BVwere assessed by Image stream ﬂow cytom-
etry of cells exposed to normoxia (N, 21% O2), hypoxia (H, 1% O2) and H2O2 (500 μM; scale bar: 10 μm). B. Mean ﬂuorescence intensity of DCF from an average of 5000 cells per treatment
group is shown from one representative experiment of triplicate repeats (Average ± SEM; ****p b 0.0001, ANOVA with Dunnett post-test, compared to normoxia). C. MitoSOX Red ﬂuo-
rescence in 253J and 253J-BVwas assessed in live cells following exposure to 18 h of normoxia (N, 21% O2) or hypoxia (H, 1%O2), with or without the addition of the superoxide scavenger
MitoTEMPO (60 μM; scale bar: 100 μm). D. Average Fluorescence per ﬁeld (n= 30–50 cells) was quantiﬁed using ImageJ (n = 3, average ± SEM; *p b 0.05, ****p b 0.0001, ANOVA with
Tukey's post-test). One replicate of three independent experiments is shown.
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redox-dependent manner
Cell migration and spheroid outgrowth were assessed to elucidate
the consequences of hypoxia on 253J-BVmetastatic behavior.We previ-
ously demonstrated thatmetastatic 253J-BV cellsmigrate at a faster rate
than 253J cells under normoxia [9]. The rate of 253J-BV migration was
further enhanced when wound-healing assays were performed under
1% O2 conditions (Fig. 6A). To mimic the metastatic spread of cells
from micro-metastases, cells were cultured as anchorage independent
spheroids and the metastatic spread of cells monitored by placing the
spheroid on ECM components. 253J-BV cells exhibited enhancedmigration from the attached spheroid on collagen I and IV under hypox-
ia when compared with normoxic conditions (Fig. 6B). The effects were
most pronounced on collagen I, a preferred substrate of MMP-1.
To assess if the enhancedmigration and spheroid outgrowth on ECM
components is dependent on the alterations of cellular redox status in
response to hypoxia, outgrowth of cells from spheroids was monitored
under increasing doses of the antioxidant NAC (Fig. 7A–C). Treatment of
253J-BV cells with NAC signiﬁcantly decreased spheroid metastatic
spread, suggesting that the migration of cells on ECM components
under hypoxia is redox-dependent (Fig. 7A–C). To demonstrate that
this effect is reliant on the induction of ECM-degrading enzymes, the
MMP inhibitor GM6001 was used and shown to signiﬁcantly abrogate
Fig. 4. Inhibition of HIF-2α expression decreasesMMP1 and VEGFmRNA transcription in response to hypoxia in 253J-BV cells. IncreasedMMP-1 (A) and VEGF (B)mRNA level in hypoxia
were attenuated by suppression of HIF-1α and HIF-2α expression using siRNA. mRNA expression was monitored using semi-quantitative real-time RT-PCR as described in Material and
methods. Speciﬁcity of siRNA towards either HIF-1α or HIF-2αwas demonstrated by monitoring HIF levels using semi-quantitative real-time RT-PCR (C & D). All data are expressed as
fold-increases in mRNA levels relative to scramble control (S) in normoxic culture conditions. (A–D: M = mock transfected controls, n = 3, average ± SEM; *p b 0.05, **p b 0.01,
***p b 0.001, ****p b 0.0001, ANOVA with Tukey's post test).
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conditions, while this effect was less pronounced under normoxia
(Fig. 7D–F). These ﬁndings suggest that hypoxia-induced redox-
regulation of MMP-1 expression exacerbates the metastatic phenotype
of metastatic tumor cells.
4. Discussion
Metastatic disease progression is accompanied by cellular changes
that include EMT induction, regulation of pro-migratory signaling and
alterations in gene transcription. In addition, metastatic tumor cells
are susceptible to hypoxia and changes in both extracellular and intra-
cellular ROS. We have previously shown that the metastatic 253J-BV
bladder cancer cells exhibit endogenous increases in intracellular ROS
compared to a related non-metastatic parental 253J cell line [1]. This en-
hanced redox status contributed to increasedMMP-9 and VEGF expres-
sion and was able to augment the clonogenicity, and migratory and
invasive behavior of 253J-BV cells [1,9]. Mechanistically, increases in
steady-state H2O2 levels were shown to regulate cellular signaling by
oxidation of key phosphatases involved in focal adhesion kinase signal-
ing, including PTPN12 and PTEN [9,47].
A number of labs have demonstrated the interplay between ROS and
hypoxia. Chandel et al. have shown that hypoxia promotes an increasein mitochondrial ROS production, resulting in PHD inhibition and stabi-
lization of HIF-1α [34–36]. Our ﬁndings indicate that metastatic tumor
cells distinctively respond to hypoxia in a redox-dependent manner
and show for the ﬁrst time that these twomechanisms converge to reg-
ulate the expression ofMMP-1. Unlike the non-metastatic parental cells
253J, only metastatic 253J-BV cells display a redox-dependent increase
in MMP-1 in response to hypoxia, which promotes migration and
spheroid outgrowth (Fig. 6). We show that the stabilization of both
HIF-1α and HIF-2α is signiﬁcantly enhanced in a redox-dependent
manner under low oxygen (Fig. 4), and that HIF-2αmay be primarily
responsible for MMP-1 regulation in this context (Fig. 5). Our data sug-
gest that a pre-existing higher steady-state intracellular ROS level, as
observed in 253J-BV cells [1], is necessary to reach the threshold for
ROS-dependent HIF stabilization and subsequent MMP-1 induction in
response to hypoxia. An altered intracellular redoxmilieumay therefore
speciﬁcally pre-dispose metastatic tumor cells to an enhanced hypoxic
response, exacerbating their metastatic phenotype. The novel ﬁnding
that metastatic cells with an increased cellular ROS milieu are more
susceptible to this mode ofMMP-1 regulation further highlights the im-
portant interplay between ROS and hypoxia in metastatic cancer
progression.
We have previously demonstrated that subtle increases in the intra-
cellular redox environment of cells contribute to the transcriptional
Fig. 5.HIF protein stabilization in response to hypoxia is redox-dependent in 253J-BV cells. A. Exposure of cells to hypoxia (H) leads to HIF-1α andHIF-2α protein stabilization as assessed
by immunoblotting. Quantiﬁcation of HIF-1α (B) andHIF-2α (C) protein levels shows that HIF stabilization is signiﬁcantly enhanced inmetastatic 253J-BV cells and redox dependent. NAC
treatment (2mmol/l) was able to decrease HIF-1α and HIF-2α stabilization in 253J-BV cells under hypoxia. NAC treatment does no inﬂuence transcriptional regulation of HIFs as assessed
by semi-quantitative real-time RT-PCR. While HIF-1α (D) and HIF-2α (E) mRNA levels are higher in 253J-BV cells under normoxia (N) compared to 253J cells, there were no signiﬁcant
changes in levels following 18 h of hypoxia or NAC treatment. All data are expressed as fold-increases in mRNA or protein levels relative to normoxia. (B–E: n = 3, average ± SEM;
*p b 0.05, **p b 0.01, ***p b 0.001, ****p b 0.0001, ANOVA with Tukey's post test).
Fig. 6.Metastatic 253J-BV cells exhibit enhancedmigration and spheroidmetastatic spread in response to hypoxia. A. Exposure of cells to hypoxia increasedmigration ofmetastatic 253J-
BV cell in a wound healing assay. B. Hypoxia increases tumor spheroid outgrowth onMMP-1 ECM substrates. 253J-BV cells were grown as spheres in ULA plates as indicated in methods
and seeded in24well plates coatedwith ECMcomponents collagen I, collagen IV andﬁbronectin.Migration of cellswasmonitored under conditions of normoxia (21%O2) andhypoxia (1%
O2) and metastatic spread measured as the area covered by migrating cells after 24 h. (A–B: n = 3, average ± SEM; *p b 0.05, Student's T-test).
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Fig. 7. Hypoxia-induced spheroid metastatic spread is abrogated by antioxidant and MMP inhibitor treatment. 253J-BV spheres were culture in ULA plates as described in methods and
seeded on collagen I, collagen IV and ﬁbronectin coated wells. Outgrowth of cells was monitored under normoxia or hypoxia for 24 h, with or without indicated doses of NAC (A–C) or
MMP inhibitor (GM6001; D–F). Metastatic spread was measured by the area covered by migrating cells after 24 h. (A–F: n = 3, average ± SEM; *p b 0.05, **p b 0.01, ***p b 0.001,
****p b 0.0001, ANOVA with Tukey's post test).
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were enhanced by overexpression of the mitochondrial superoxide
dismutase Sod2, we were able to demonstrate that MMP-1 redox-
regulation occurs through mitogen-activated protein kinase (MAPK)
signaling pathways, JNK and ERK1/2, that result in the transcriptional
regulation of redox-sensitive elements of the MMP-1 promoter [24–
26,46]. In the presentmanuscript we show for the ﬁrst time that hypox-
ia and ROS converge to drive aberrantMMP-1 inmetastatic tumor cells.
While other studies have not linked ROS to the regulation of MMP-1
under low O2, it has been reported that MMP-1 transcription is regulat-
ed by hypoxia [48–51]. Interestingly, a recent report shows that there
may be a feed-back mechanism between MMP-1 and HIF regulation.
In human alveolar epithelial cells MMP-1 expression is enhanced in
response to hypoxia and enforced expression of MMP-1 can in turn
enhance HIF1-α protein levels [52]. Unlike some other hypoxia-
responsive genes, the regulation of MMP-1 appears to require
prolonged exposure to low O2[50]. While HIF-1α has been implicated
in MMP-1 regulation [49], some studies have found that this regulation
is elicited in a HIF-1α-independent manner. It was found that CREB and
NF-kB, aswell as HIF-2α, are involved in hypoxia-mediated induction of
MMP-1 [48,50,51]. This is consistent with our results showing that HIF-
2α knockdown more effectively attenuated MMP-1 expression rather
than HIF-1α loss (Fig. 4).
Both HIF-1α and HIF-2α are expressed in various tumor types and
their increased levels are associated with tumor aggressiveness, angio-
genesis and poor patient prognosis. However, HIF-2α has recently
been associated with tumor stem cells and implicated as a more impor-
tant driver of tumor development and metastasis [32,33,53–57]. One
suggested mechanism for HIF-2α speciﬁc regulation in this context is
the differential regulation of HIF-1α and HIF-2α by the hypoxia associ-
ated factor (HAF) protein. Increased HAF levels have been detected in
various tumor types and it appears to play an important role in hypoxia
signaling by turning on the HIF-2α response under prolonged hypoxia
[58]. Althoughwe did not observe any change inHAFmRNA and proteinlevels in 253J-BV cells during hypoxic exposure, we detected higher
basal expression of HAF protein in 253J-BV cells compared with 253J
cells (Supplementary Fig. 2). While this increased HAF expression in
metastatic 253J-BV cells was not signiﬁcantly abrogated following
NAC treatment, we are further investigating if the enhanced redox envi-
ronment of 253J-BV cells contributes to enhanced HAF expression.
We previously demonstrated that 253J-BV cells display increased
steady state H2O2 levels and increased mitochondrial oxidation of the
redox sensitive roGFP probe [1], suggesting that mitochondrial steady-
state redox tonemay be responsible for redox-dependent HIF stabiliza-
tion and expression of MMP-1 under hypoxia. While we demonstrated
increased oxidation of the mitochondria targeted probe MitoSOX in
253J-BV cells in response to hypoxia, the addition of the O2•− scavenger
MitoTEMPOonly slightly decreased the oxidation of the dye (Fig. 3C and
D), making it difﬁcult to conclude whether increases in O2•− are directly
generated as a consequence of hypoxia. Unlike NAC, MitoTEMPO failed
to inhibit MMP-1 expression increases in response to hypoxia (Supple-
mentary Fig. S3).While further experimental evidence is required, these
data suggest that the effects of hypoxia on MMP-1 expression cannot
simply be attributed to changes in mitochondrial O2•− production. In-
stead, it is likely that mitochondria generated ROS and concomitant
redox reactions, including the generation of secondary reactive species,
including H2O2 and •OH, and the oxidation of mitochondrial and cyto-
plasmic proteins, contribute to an altered cellular redox state that inﬂu-
ences HIF stabilization and MMP-1 expression. This may also explain
the observation that the glutathione precursor NAC consistently abro-
gates hypoxia-induced MMP-1 expression. The stabilization of HIF pro-
teins in response to hypoxia-generated ROS has been attributed to
various processes including PHD inhibition, where Fe(II) oxidation to
Fe(III) limits Fe(II) availability for maximal PHD activity [40,41] In addi-
tion, HIF-2α can be regulated by the redox-sensitive deacetylase Situin-
1, and it has been demonstrated that NADPH oxidase (NOX)-derived
ROS enhances HIF-2αmRNA translation, as a consequence of redox reg-
ulation of mTORC2 [43,59]. Interestingly, the ROS-mediated protein
2601D.H. Shin et al. / Biochimica et Biophysica Acta 1852 (2015) 2593–2602stabilization of HIF-1α and HIF-2α in response to hypoxia was speciﬁ-
cally observed in 253J-BV cells and not in 253J cells (Fig. 5), again sug-
gesting that higher steady-state ROS levels are necessary to reach the
threshold for ROS-dependentHIF activation in response to hypoxia. Fur-
ther, abrogation of hypoxia-mediated HIF stabilization, MMP-1 tran-
scription and 253J-BV migration by NAC show that changing the
redox status of metastatic tumor cells can inﬂuence their response to
hypoxia and prevent metastatic behavior. This supports previous work
demonstrating that NAC elicits its main anti-tumor effects by
preventing HIF stabilization [60].
In summary, the current study establishes a redox-dependent link to
the hypoxia-mediated induction of MMP-1 expression, which accentu-
ates the metastatic phenotype of bladder cancer cells. Our data suggest
that this may be associatedwith the pre-existing increase in the steady-
state redox balance of metastatic tumor cells. Thus, the intracellular
redox status needs to be taken into considerationwhen assessing the ef-
fects of hypoxia on cells, as well as in the development of treatment
strategies for metastatic disease.
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